GL Pharm Tech Corp. Logo

GL Pharm Tech Corp.

Develops improved drugs and generics, and licenses proprietary drug formulation technologies.

204840 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 달래내로 46 성남글로벌융합센터 210호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GL Pharm Tech Corp. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in creating Incrementally Modified Drugs (IMDs), which are improved versions of existing medications designed to offer benefits such as reduced side effects or modified-release formulations. It provides generic drugs and licenses its proprietary drug formulation and delivery platform technologies to other pharmaceutical firms. The company's core competency lies in developing innovative formulations to enhance the efficacy and patient profile of established therapies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GL Pharm Tech Corp. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 00:00
Regulatory News Service
불성실공시법인미지정 (지정유예)
Korean 5.6 KB
2025-08-25 00:00
Regulatory News Service
불성실공시법인지정예고 (공시번복)
Korean 4.9 KB
2025-08-14 00:00
M&A Activity
[기재정정]주요사항보고서(회사합병결정)
Korean 96.7 KB
2025-08-14 00:00
M&A Activity
기타주요경영사항 (회사 합병결정 철회)
Korean 7.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB

Automate Your Workflow. Get a real-time feed of all GL Pharm Tech Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GL Pharm Tech Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.